ArthroCare Buys ENTrigue Surgical For $45M

Austin-based surgical device firm ArthroCare said last week that it has acquired ENTrigue Surgical, a developer of treatments for sinusitis. ArthroCare paid $45M in cash for ENTrique. ArthroCare was advised by Piper Jaffray & Co. and DLA Piper in the deal. ENTrigue was advised by J.P. Morgan Securities and Norton Rose Fulbright.